Search Results - "WENANDY, Lynn"
-
1
The Immunogenicity of the hTERT540-548 Peptide in Cancer
Published in Clinical cancer research (01-01-2008)“…Human telomerase reverse transcriptase (hTERT), the catalytic subunit of telomerase, is an attractive target antigen for cancer immunotherapy due to its…”
Get full text
Journal Article -
2
Identification of a new hTERT-derived HLA-A0201 restricted, naturally processed CTL epitope
Published in Cancer Immunology, Immunotherapy (01-11-2007)“…By the use of a neural network capable of performing quantitative predictions of peptides binding to HLA-A*0201 molecules, we identified a number of nonamer…”
Get full text
Journal Article -
3
Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4 + T cells by the microRNA miR-125b
Published in Nature immunology (01-08-2011)“…MicroRNAs are post-transcriptional regulators of gene expression. Pagani and colleagues identify specific microRNA signatures and their target genes in various…”
Get full text
Journal Article -
4
Multiparameter single-cell profiling of human CD4+FOXP3+ regulatory T-cell populations in homeostatic conditions and during graft-versus-host disease
Published in Blood (05-09-2013)“…Understanding the heterogeneity of human CD4+FOXP3+ regulatory T cells (Tregs) and their potential for lineage reprogramming is of critical importance for…”
Get full text
Journal Article -
5
Therapeutic Dendritic Cell Vaccination of Patients With Metastatic Renal Cell Carcinoma : A Clinical Phase 1/2 trial
Published in Journal of immunotherapy (1997) (01-10-2008)“…Therapeutic dendritic cell (DC) vaccination against cancer is a strategy aimed at activating the immune system to recognize and destroy tumor cells. In this…”
Get full text
Journal Article -
6
Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer
Published in Cytotherapy (Oxford, England) (01-08-2011)“…Abstract Background aims Adoptive transfer of tumor-infiltrating lymphocytes (TIL) has proven effective in metastatic melanoma and should therefore be explored…”
Get full text
Journal Article -
7
RhoC a new target for therapeutic vaccination against metastatic cancer
Published in Cancer Immunology, Immunotherapy (01-12-2008)“…Most cancer deaths are due to the development of metastases. Increased expression of RhoC is linked to enhanced metastatic potential in multiple cancers…”
Get full text
Journal Article -
8
Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in [CD4.sup.+] T cells by the microRNA miR-125b
Published in Nature immunology (01-08-2011)“…MicroRNAs are small noncoding RNAs that regulate gene expression post-transcriptionally. Here we applied microRNA profiling to 17 human lymphocyte subsets to…”
Get full text
Journal Article -
9
Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4 super(+) T cells by the microRNA miR-125b
Published in Nature immunology (19-07-2011)“…MicroRNAs are small noncoding RNAs that regulate gene expression post-transcriptionally. Here we applied microRNA profiling to 17 human lymphocyte subsets to…”
Get full text
Journal Article -
10
Distinct microRNA signatures in human lymphocyte subsets and enforcement of CD4+ T cell naïveness by miR-125b
Published in Nature immunology (26-06-2011)“…MicroRNAs are small non-coding RNAs that regulate gene expression post-transcriptionally. Here we applied microRNA profiling in seventeen human lymphocyte…”
Get full text
Journal Article -
11
P-25 Vaccination with autologous dendritic cells, pulsed with tumor antigens for treatment of patients with malignant melanoma: phase I/II study
Published in Melanoma research (01-02-2007)Get full text
Journal Article